Gerald P. Oetzel

CFO

Scott Rathgaber

CEO

3 past transactions

Flywheel.io

Series D in 2023
Flywheel is a data management and analysis platform built specifically for scientists and the researcher's workflow. They empower research momentum by focusing on data and medical image capture, content management, scientific computation, and collaboration. With reproducible research in mind, they combine open-source methods from top universities, a modern web user interface, and an extensible compute engine based on containerization technology. The result is a software platform to accelerate discovery and help researchers do science, not IT. Flywheel accelerates new scientific discoveries in life-science, biotech, and academic imaging research through cloud-scale collaboration. As a result, imaging researchers are able to avoid innovation bottlenecks, and accelerate discovery by doing more science, and less IT.

Bellin Health

Acquisition in 2022
Bellin Health is an integrated healthcare delivery system based in Green Bay, Wisconsin, offering a comprehensive range of medical services. The organization includes hospitals, specialty care clinics, psychiatric centers, and fitness facilities, providing preventive and specialized care in areas such as cardiology, orthopedics, sports medicine, digestive health, mental health, and primary care. Bellin Health's services also encompass rehabilitation, surgery—including robotic-assisted procedures—cancer treatment, pulmonary care, and emergency services. Additionally, the system features a fitness center that offers group exercise, personal training, lifestyle medicine, weight management programs, and wellness events, promoting overall health and well-being for its patients and the community.

Digital Diagnostics

Series B in 2022
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing healthcare through technology. Founded in 2010 by Michael Abramoff, MD, PhD, the company has developed a suite of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR, which identifies diabetic retinopathy; IDx-G, which monitors glaucoma indicators; and IDx-AMD, designed to detect age-related macular degeneration. The company also offers algorithms for diagnosing conditions such as Alzheimer's disease, cardiovascular disease, and stroke risk. By providing these innovative solutions, Digital Diagnostics aims to improve the quality, accessibility, equity, and affordability of healthcare worldwide. Operating from Coralville, Iowa, the company distributes its products both domestically and internationally, striving to integrate autonomous AI into standard clinical practices and enhance patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.